11/19/2026
What do the 12-month DEEPER REVEAL results tell us about treating challenging BTK CLTI?
In patients with complex, calcified infrapopliteal lesions, treatment with the Spur® Peripheral Retrievable Stent System following predilatation demonstrated sustained clinical outcomes at 12 months:
• Sustained primary patency
• Freedom from clinically driven target lesion revascularization (CD-TLR)
• Complete wound healing and limb salvage
Explore the carousel to discover the key clinical outcomes.
🔗 Learn more about the Spur Stent System:
https://www.reflowmedical.com/spur/
🔗 Important U.S. Safety Information and full Indications for Use:
https://www.reflowmedical.com/resources/